SQZ | SQueeZe This One | LONGSQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with other immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. SQZ Biotechnologies Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.
SQZ
Serica Energy #SQZ - WATCHING FOR ENTRY - Holding well at 78.6% fibs.
Closing above 8ema (orange line) will be a bullish move and a optimum entry.
If wrong then I will be looking at the 50% fibs & 200ma line for a bounce entry.
Long #SQZProduction resumed... oil flying
Undervalued fundamentally. Cup & handle pattern apparently in play with golden crosses forming on daily and hourly timeframes currently.
